Literature DB >> 25201563

Antibacterial and anti-inflammatory activity of a temporin B peptide analogue on an in vitro model of cystic fibrosis.

Valentino Bezzerri1, Concetta Avitabile, Maria Cristina Dechecchi, Ilaria Lampronti, Monica Borgatti, Giulia Montagner, Giulio Cabrini, Roberto Gambari, Alessandra Romanelli.   

Abstract

Natural peptides with antimicrobial properties are deeply investigated as tools to fight bacteria resistant to common antibiotics. Small peptides, as those belonging to the temporin family, are very attractive because their activity can easily be tuned after small modification to their primary sequence. Structure-activity studies previously reported by us allowed the identification of one peptide, analogue of temporin B, TB_KKG6A, showing, unlike temporin B, antimicrobial activity against both Gram-positive and Gram-negative bacteria. In this paper, we investigated the antimicrobial and anti-inflammatory activity of the peptide TB_KKG6A against Pseudomonas aeruginosa. Interestingly, we found that the peptide exhibits antimicrobial activity at low concentrations, being able to downregulate the pro-inflammatory chemokines and cytokines interleukin (IL)-8, IL-1β, IL-6 and tumor necrosis factor-α produced downstream infected human bronchial epithelial cells. Experiments were carried out also with temporin B, which was found to show pro-inflammatory activity. Details on the interaction between TB_KKG6A and the P. aeruginosa LPS were obtained by circular dichroism and fluorescence studies.
Copyright © 2014 European Peptide Society and John Wiley & Sons, Ltd.

Entities:  

Keywords:  Pseudomonas aeruginosa; anti-inflammatory; antimicrobial; peptide; pro-inflammatory; temporin

Mesh:

Substances:

Year:  2014        PMID: 25201563     DOI: 10.1002/psc.2674

Source DB:  PubMed          Journal:  J Pept Sci        ISSN: 1075-2617            Impact factor:   1.905


  9 in total

1.  Chitosan nanoparticles loaded with the antimicrobial peptide temporin B exert a long-term antibacterial activity in vitro against clinical isolates of Staphylococcus epidermidis.

Authors:  Anna M Piras; Giuseppantonio Maisetta; Stefania Sandreschi; Matteo Gazzarri; Cristina Bartoli; Lucia Grassi; Semih Esin; Federica Chiellini; Giovanna Batoni
Journal:  Front Microbiol       Date:  2015-04-28       Impact factor: 5.640

2.  Minor sequence modifications in temporin B cause drastic changes in antibacterial potency and selectivity by fundamentally altering membrane activity.

Authors:  Giorgia Manzo; Philip M Ferguson; V Benjamin Gustilo; Charlotte K Hind; Melanie Clifford; Tam T Bui; Alex F Drake; R Andrew Atkinson; J Mark Sutton; Giovanna Batoni; Christian D Lorenz; David A Phoenix; A James Mason
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

Review 3.  Approaches to Targeting Bacterial Biofilms in Cystic Fibrosis Airways.

Authors:  Isaac Martin; Valerie Waters; Hartmut Grasemann
Journal:  Int J Mol Sci       Date:  2021-02-22       Impact factor: 5.923

4.  SSTP1, a Host Defense Peptide, Exploits the Immunomodulatory IL6 Pathway to Induce Apoptosis in Cancer Cells.

Authors:  Shyla Gopalakrishnan; Soumya Krishnan Uma; Gayathri Mohan; Amrutha Mohan; Geetha Shanmugam; Vineeth T V Kumar; Sreekumar J; Sivakumar K Chandrika; Dileep Vasudevan; Sai Ravi Chandra Nori; Shijulal Nelson Sathi; Sanil George; Tessy Thomas Maliekal
Journal:  Front Immunol       Date:  2021-11-19       Impact factor: 7.561

5.  Chiral Fibers Formation Upon Assembly of Tetraphenylalanine Peptide Conjugated to a PNA Dimer.

Authors:  Andrea Mosseri; Maria Sancho-Albero; Marilisa Leone; Donatella Nava; Francesco Secundo; Daniela Maggioni; Luisa De Cola; Alessandra Romanelli
Journal:  Chemistry       Date:  2022-05-23       Impact factor: 5.020

6.  New Perspectives in the Antimicrobial Activity of the Amphibian Temporin B: Peptide Analogs Are Effective Inhibitors of Candida albicans Growth.

Authors:  Anant Kakar; Jeanett Holzknecht; Sandrine Dubrac; Maria Luisa Gelmi; Alessandra Romanelli; Florentine Marx
Journal:  J Fungi (Basel)       Date:  2021-06-07

7.  Temporizin and Temporizin-1 Peptides as Novel Candidates for Eliminating Trypanosoma cruzi.

Authors:  André L A Souza; Robson X Faria; Kátia S Calabrese; Daiane J Hardoim; Noemi Taniwaki; Luiz A Alves; Salvatore G De Simone
Journal:  PLoS One       Date:  2016-07-06       Impact factor: 3.240

8.  D-BMAP18 Antimicrobial Peptide Is Active In vitro, Resists to Pulmonary Proteases but Loses Its Activity in a Murine Model of Pseudomonas aeruginosa Lung Infection.

Authors:  Mario Mardirossian; Arianna Pompilio; Margherita Degasperi; Giulia Runti; Sabrina Pacor; Giovanni Di Bonaventura; Marco Scocchi
Journal:  Front Chem       Date:  2017-06-19       Impact factor: 5.221

9.  Anti-Infectives Restore ORKAMBI® Rescue of F508del-CFTR Function in Human Bronchial Epithelial Cells Infected with Clinical Strains of P. aeruginosa.

Authors:  Onofrio Laselva; Tracy A Stone; Christine E Bear; Charles M Deber
Journal:  Biomolecules       Date:  2020-02-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.